Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-30

Clinical Trial Update: Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether fish oil supplementation reduces the frequency and duration of atrial fibrillation episodes in patients with paroxysma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil

Snippet

Sponsor: Melbourne Health | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED